Alexander Straub, Principal Research Scientist, Bayer Schering Pharma AGMonday, 28 March 2011 at 17:00 Add to Calendar ▼2011-03-28 17:00:002011-03-28 18:00:00Europe/LondonAlexander Straub, Principal Research Scientist, Bayer Schering Pharma AGMedChem Europe in MunichMunichSELECTBIOenquiries@selectbiosciences.comRiociguat, currently under development by Bayer Schering Pharma, is a new guanylate cyclase stimulator which acts differently compared to the natural stimulator NO. SAR and pharmacology are presented. |
Add to Calendar ▼2011-03-28 00:00:002011-03-29 00:00:00Europe/LondonMedChem EuropeMedChem Europe in MunichMunichSELECTBIOenquiries@selectbiosciences.com